Get the Stockscreener App
9.40
2.93%
0.2675
Daxor Corporation stock is traded at $9.40, with a volume of 16,906.
It is up +2.93% in the last 24 hours and up +9.21% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$9.1325
Open:
$9.13
24h Volume:
16,906
Relative Volume:
2.55
Market Cap:
$44.30M
Revenue:
$1.28M
Net Income/Loss:
$280.60K
P/E Ratio:
-117.50
EPS:
-0.08
Net Cash Flow:
-
1W Performance:
+8.67%
1M Performance:
+9.21%
6M Performance:
-4.08%
1Y Performance:
+17.79%
1-Day Range:
$9.00
$9.48
1-Week Range:
$8.51
$9.48
52-Week Range:
$7.11
$10.04
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
(DXR) On The My Stocks Page - Stock Traders Daily
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24 - The Manila Times
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC - GlobeNewswire
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Long Term Trading Analysis for (DXR) - Stock Traders Daily
Short Interest in Daxor Co. (NASDAQ:DXR) Rises By 39.6% - Defense World
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device - The Manila Times
(DXR) Long Term Investment Analysis - Stock Traders Daily
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024 - GlobeNewswire
Daxor (NYSEAMERICAN:DXR) Stock Passes Above Two Hundred Day Moving Average of $0.00 - Defense World
(DXR) Technical Data - Stock Traders Daily
Daxor announces review published in journal on BVA - TipRanks
Newly Published Review Highlights the Pivotal Role of - GlobeNewswire
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management - StockTitan
Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets - Defense World
Daxor secures $300K from LaunchTN for blood analyzer tech - Investing.com India
Daxor receives $300K matching fund award from Launch Tennessee - TipRanks
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee - GlobeNewswire
DXRDaxor Corporation Latest Stock News & Market Updates - StockTitan
Central Florida hospital implements Daxor BVA-100 blood volume diagnostic - TipRanks
Leading Central Florida Hospital Implements Daxor’s - GlobeNewswire
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care - StockTitan
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter - GlobeNewswire
Daxor reports doubled revenue, secures government contracts - Investing.com
Daxor reports doubled revenue, secures government contracts By Investing.com - Investing.com Canada
Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time - TipRanks
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network - GlobeNewswire
Daxor (DXR) Owner Earnings per Share (TTM) : 0.00 (As of Dec. 2023) - GuruFocus.com
Daxor (NASDAQ:DXR) Stock Price Down 4.6% - Defense World
Daxor Corporation Awarded $1.9M Contract by The U.S. Air - GlobeNewswire
Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer - StockTitan
Daxor Expands to Three New Facilities as Blood Volume Analysis Technology Gains Momentum Nationwide - Marketscreener.com
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide - GlobeNewswire
Daxor Corporation Awarded New U.S. Defense Health Agency - GlobeNewswire
Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer - StockTitan
Daxor awarded $550K matching-fund extension from U.S. DHA - TipRanks
Daxor Corp holds annual meeting, re-elects directors By Investing.com - Investing.com Canada
Daxor Corp holds annual meeting, re-elects directors - Investing.com
(DXR) Trading Report - Stock Traders Daily
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide - GlobeNewswire
Daxor’s BVA-100 blood volume diagnostic expands to three new centers - TipRanks
Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume Analysis: New Data Presented at the American College of Cardiology Congress - Yahoo Movies UK
Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume ... - Yahoo Movies UK
Short Interest in Daxor Co. (NASDAQ:DXR) Grows By 15.2% - Defense World
Learn to Evaluate (DXR) using the Charts - Stock Traders Daily
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure ... - GlobeNewswire
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting - Yahoo Finance
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):